Takeda Pharmaceutical Company Ltd. has developed a curated kinase inhibitor library, selected from profiling against more than 300 protein kinases. To foster partnerships based on complementary strengths between academia and industry, they are seeking researchers with access to cell-based phenotypic assays related to gastroenterology. Successful applicants will receive up to $15,000 USD for project costs (however, this can be increased where necessary with the exact funding amount at Takeda’s discretion) to test the library in their own laboratory. Additionally...
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.